Results 201 to 210 of about 140,144 (311)

Impact of Routine Respiratory Pathogen Panel Test on Outcome of Pediatric Oncology Patients With Febrile Neutropenia. [PDF]

Cancer Rep (Hoboken)
Gaston F, Tran A, Odhiambo C, Bakir M.
europepmc   +1 more source

[Febrile neutropenia].

Ryoikibetsu shokogun shirizu, 2001
openaire   +2 more sources

Chronic Neutropenia [PDF]

Archives of Disease in Childhood, 1957
openaire   +2 more sources

Novel BTK inhibitors and degraders for relapsed/refractory CLL/SLL: latest updates from ASH 2025 annual meeting. [PDF]

J Hematol Oncol
Sharma P, Jiang H, Liu D.
europepmc   +1 more source

A Case Report of Shwachman-Diamond Syndrome Caused by Heterozygous Variants in the EFL1 Gene and Literature Review. [PDF]

Mol Genet Genomic Med
Zhou X, Li H, Yang X, Wang C, Zhang W.
europepmc   +1 more source

A strategic approach to managing Immune Effector Cell-Associated Hematotoxicity (ICAHT) during chimeric antigen receptor T-cell therapy. [PDF]

Blood Res
Yoon SE.
europepmc   +1 more source

Neutropenia management

Annals of Oncology, 2006
openaire   +2 more sources

Blinatumomab for treatment of children with acute lymphoblastic leukaemia in Hong Kong: A cost‐effectiveness analysis

British Journal of Haematology, EarlyView.
Summary To assess the cost‐effectiveness of blinatumomab plus chemotherapy for paediatric patients from Hong Kong public healthcare provider's perspective, a 10‐year Markov model was designed to simulate outcomes in paediatric patients with newly diagnosed standard‐risk B‐cell ALL at: (1) average risk and (2) high risk of relapse.
Mingjun Rui, Yin Ting Cheung, Hui Zhang, Qiran Wei, Yingcheng Wang, Jiaqi Shi, Chi Kong Li, Joyce H. S. You   +7 more
wiley   +1 more source

Infectious complications after CAR T-cell therapy: mechanisms, risk stratification, and prevention. [PDF]

Blood Res
Lee E, Lee JH, Kim HR, Huh SJ, Lee S, Oh SY, Kim SH, Lee H.   +7 more
europepmc   +1 more source